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Abstract 36 
Cholecystokinin (CCK) is a gastrointestinal hormone, which regulates many physiological 37 
functions such as satiety by binding to the CCK receptor (CCKR). Molecules, which 38 
recognize this receptor can mimic or block CCK signaling and thereby influence CCKR-39 
mediated processes. We have set up a quantitative heterologous assay with CHO cells over-40 
expressing the rat CCK1 receptor to screen for such candidate molecules. Receptor activation, 41 
induced by agonist binding, is followed by an intracellular calcium increase, which was 42 
monitored using a fluorescent sensor dye. For quantification of the calcium increase, a 43 
population average technique using a fluorescence plate reader was optimized and 44 
subsequently compared with a single-cell approach using confocal microscopy. With both 45 
strategies, dose-response curves were generated for the natural agonist CCK-8S, the partial 46 
agonist JMV-180 as well as the antagonist lorglumide. Significant differences were found 47 
between the ligands and a strong correspondence was observed between both methods in 48 
terms of maximum response and median effect concentrations. Both highly sensitive methods 49 
proved complementary: whereas the plate reader assay allowed faster, high throughput 50 
screening, the confocal microscopy identified single-cell variations and revealed factors that 51 
reduce specificity and sensitivity. 52 
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1. Introduction 57 
Cholecystokinin (CCK) is a hormone and neuropeptide, which induces satiety and which 58 
regulates many physiological processes like gall bladder contraction, gastrointestinal motility, 59 
pancreas secretion, gastric acid secretion, panic, and anxiety [12]. CCK exerts its effects via 60 
binding to members of the CCK receptor (CCKR) family. Among the major subtypes are 61 
CCK1 receptor (CCK1R), mainly expressed in the gastrointestinal channel, and CCK2 62 
receptor (CCK2R), mainly expressed in the brain [7]. Due to their multifaceted role, CCK 63 
receptors form an important target in the treatment of several diseases. Both agonistic and 64 
antagonistic ligands for the CCKR are considered for therapeutic strategies [3,16].   65 
CCKR are G protein-coupled receptors, which upon activation, elicit an inositol 66 
trisphosphate (IP3)-induced calcium release from the endoplasmic reticulum [7,13]. This 67 
intracellular Ca2+-flux is a measure for the activation of the receptor and can be visualized 68 
with fluorescent sensor dyes [12]. Different cell systems functionally expressing one of the 69 
CCKR subtypes exist and can be used to screen for ligands with agonistic or antagonistic 70 
CCKR binding activity [4,8,14,15]. However, the use of diverse cell types, fluorescent dyes 71 
and measuring techniques makes it difficult to compare the results from different studies on 72 
the effectiveness of several ligands. Here, we established a fully controlled, standardized and 73 
sensitive cell-based bioassay in 96-well plates to screen and characterize components with 74 
CCK1R activity. For validation, the changes in fluorescence intensity observed with a 75 
population average technique using a fluorescence plate reader were compared with a single-76 
cell approach using confocal microscopy. Cross-validation of both measuring techniques 77 
resulted in a sensitive and specific assay, which can be used for high throughput screening of 78 
molecules and protein hydrolysates that interact with the CCK1R. The discovery of these 79 
products may underlie the development of novel therapeutic formulations or new functional 80 
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foods and nutraceuticals, which induce satiety or have an effect on other CCK1R-mediated 81 
pathologic conditions.  82 
 83 
2. Materials and Methods 84 
2.1. Cell lines and chemicals 85 
CHO (Chinese Hamster Ovary) cells functionally expressing the rat CCK1R (CHO-CCK1R) 86 
were established by Prof. Peter Willems [15] and native CHO-K1 cells were obtained from 87 
Prof. Georges Leclercq (Ghent University Hospital, Department of Clinic Biology, 88 
Microbiology and Immunology, Ghent Belgium). Advanced Dulbecco’s modified Eagle’s 89 
medium and Ham’s F12 medium (1:1) (DMEM-F12), fetal bovine serum (FBS), geneticin (G-90 
418 antibiotic), Fluo-4AM, Pluronic F-127 and Hank’s buffered salt solution (HBSS) were 91 
purchased from Invitrogen (Paisley, UK), probenecid, lorglumide ((±)-4-[(3,4-92 
dichlorobenzoyl)amino]-5-(dipentylamino)-5-oxopentanoic acid sodium salt; CR-1409), 93 
bovine serum albumin (BSA) and HEPES from Sigma-Aldrich (St.-Louis, MO), sulfated 94 
cholecystokinin octapeptide (CCK-8S) and thrombin receptor activating protein (TRAP-7) 95 
from Bachem (Weil am Rhein, Germany), and JMV-180 (Boc-Tyr(SO3H)-Nle-Gly-Trp-Nle-96 
Asp-2-phenylethylester) from Research Inc. (Barnegat, NJ). Clear bottom black 96-well plates 97 
were purchased from Greiner (Frickenhausen, Germany). 98 
 99 
2.2. Cell culture 100 
CHO-CCK1R and CHO-K1 cells were grown at 37°C and 5% CO2 in advanced DMEM-F12 101 
supplemented with 1% streptomycin and penicillin, 1% L-glutamine and 10% FBS. The 102 
medium of CHO-CCK1R cells was supplemented with 10 µl/ml geneticin to maintain a stably 103 
transfected culture. 104 
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 105 
2.3. Cell-based bioassay to screen for CCK1R activity 106 
The determination of the intracellular free Ca2+ concentration was adapted from a method 107 
previously reported by Foltz et al. [1]. The fluorescent probe that was used in this assay is the 108 
hydrophobic Fluo-4AM, a cell-permeant acetoxymethyl (AM) ester, which is hydrolyzed by 109 
cellular esterases and becomes fluorescent upon Ca2+-binding. One half of a 96-well plate is 110 
seeded with CHO-CCK1R cells and the other half with CHO-K1 cells, in both cases at 40,000 111 
cells per well. Cells were incubated at 37°C and 5% CO2 for 20-24 h to allow attachment. 112 
Next, the medium was removed and 50 µl of DMEM-F12 supplemented with 4 µM Fluo-113 
4AM, 0.02% (w/v) of the surfactant pluronic, 4.55 mg/ml BSA, and 1.6 mM of the anion 114 
transport inhibitor probenecid was added to the wells for 1 h at 19°C, as was determined as 115 
the ideal dye loading temperature in preliminary experiments. Subsequently, the wells were 116 
washed twice with 150 µl of HBSS supplemented with 20 mM HEPES, 2.5 mM probenecid 117 
and 10 mg/ml BSA and finally 100 µl of modified HBSS was added to the wells. Lorglumide 118 
was added at a final concentration of 0–40 µM, 20 min before the start of the experiment. 119 
Receptor activation leads to a rapid increase in intracellular calcium concentration (within 0–120 
30 s). Hence, fluorescence intensity was measured kinetically. Two setups were used: a 121 
fluorescence plate reader and a confocal microscope. In the first setup, an Infinite pro 200 122 
(Tecan, Männedorf, Switzerland) multimode plate reader with automated injection system 123 
was handled using i-control™ software. Excitation and emission wavelengths were set to 480 124 
nm and 520 nm respectively, using Quad4 monochromators™ technology. In the second 125 
setup, a Nikon A1r confocal laser scanning microscopy system (Nikon Instruments Inc., 126 
Melville, NY) was used, mounted on a Nikon Ti-E inverted epifluorescence microscope and 127 
equipped with a microscope incubator, Perfect Focus System and resonant scanner. Multiwell 128 
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dishes were screened, with a Plan Fluor 40 x/0.75 dry objective at full field of view (636 µm x 129 
636 µm), resulting in a pixel size of 1.24 µm x 1.24 µm. Fluo-4AM was excited using a 488 130 
nm multi-line Ar laser and fluorescence was detected through a 525/50 nm bandpass filter. 131 
On both platforms a similar measurement protocol was applied. Measurement started 132 
30 min after washing to allow complete intracellular cleavage of the Fluo-4AM ester. After 133 
washing, the plates were immediately placed in the plate reader or microscope incubator to 134 
equilibrate at the measurement temperature of 31°C, as determined in preliminary 135 
experiments. Each well was measured separately. Fluorescence was acquired at 2.5 fps with 136 
the plate reader and 3 fps with the confocal microscope. Ligands were added in fluxo, i.e. 137 
during acquisition: the basal fluorescence of a well was measured for 6 s after which 100 µl of 138 
the sample (diluted in modified HBSS) was added instantaneously while the measurement 139 
continued for another 34 s. In the plate reader, sample addition was performed automatically, 140 
while in the confocal microscopy the sample was added using an electronic repeating pipette 141 
(Handystep, BrandTech Scientific Inc, Essex, CT). Each sample concentration was measured 142 
in 5 wells (technical replicates) for both cell types and every experiment was repeated 3-4 143 
times (biological replicates).  144 
 145 
2.4. Image analysis 146 
Confocal images were analyzed with ImageJ freeware (National Institute of Health, Bethesda, 147 
MD). For population average measurements, the average fluorescence intensity (per pixel) 148 
over the entire image was measured in unprocessed recordings. For single-cell analysis, the 149 
following workflow was designed: first, images were aligned by means of a rigid registration 150 
(translation and rotation) to remove superimposed motion e.g. due to thermal drift. Next, an 151 
average projection was made of the complete time stack to provide a well-contrasted image of 152 
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all the cells by averaging out the noise. This approach of temporal averaging works efficiently 153 
even in the absence of an overt calcium flux (e.g. in CHO-K1 cells, cfr. Supplementary Fig. 154 
1). An extra smoothing step, by means of Gaussian filtering (sigma=1) removed the 155 
remaining noise and allowed for segmenting the cells in a subsequent thresholding step 156 
(Huang autothreshold). Touching cells were separated by local maxima finding and 157 
conditional region growing, resulting in a complete set of regions of interest (ROI), 158 
corresponding to the cell boundaries. All ROI were inspected and manually corrected, where 159 
required. Finally, a particle analysis was performed to measure the average pixel intensity per 160 
cell ROI (i.e. integrated intensity in a cellular ROI, divided by the ROI area in pixels) through 161 
time. This metric was selected to avoid cell-size dependent variations in signal intensity. 162 
Single cell results were processed and summarized using Matlab 7.10.0 (R2010a, The 163 
Mathworks Inc., Natick, MA). 164 
 165 
2.5. Data analysis and statistics  166 
For calculation of dose-response curves the following procedure was applied. Per time point i, 167 
fluorescence measurements (Fi) were normalized to the average fluorescence before sample 168 
addition, which corresponds to the average fluorescence in the first 6 s of the recording (F0), 169 
thereby correcting for differences in the amount of basal fluorescence, due to variations in cell 170 
density, dye concentration and/or free calcium concentration. Average normalized 171 
fluorescence values of 5 technical replicates were corrected for non-specific responses and 172 
background fluorescence by subtracting the average normalized fluorescence values obtained 173 
for CHO-K1 cells per time point and per condition. Hence, the relative fluorescence (RF) was 174 
calculated using the following formula: RFi =
Fi CHO−CCK1R( )
F0 CHO−CCK1R( ) −
Fi CHO− K1( )
F0 CHO− K1( )  and 175 
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plotted as a function of time. Subsequently, a single metric was derived from the RF curves: 176 
the net response was calculated as the sum of relative fluorescence values, from the moment 177 
of sample addition until the end of the acquisition (net response = RFi
i=6s
40s
∑ ). All net responses 178 
were expressed as a percentage of the maximal net response of CCK-8S (induced by a 179 
concentration of 1 nM). The inhibiting effect of the antagonist was calculated as 100% minus 180 
the net response. From these results, sigmoid dose-response curves for the percentage of the 181 
maximum response/percentage of inhibition versus sample concentration were derived with 182 
Prism v4 software (GraphPad Prism, La Jolla, CA) and median response concentrations, i.e. 183 
effective EC50 and/or inhibitory IC50 values, were calculated for the agonists and antagonists, 184 
respectively [19]. The EC50 value represents the agonist concentration at which 50% of its 185 
maximum response is reached. The IC50 value is the antagonist concentration, which inhibits 186 
50% of the maximum response of CCK-8S (1 nM). The median response concentrations of 187 
agonists and antagonists are the mean of at least three independently repeated dose-response 188 
curves (biological replicates), which are based on 5 repeated measurements (technical 189 
replicates) for each concentration.   190 
Median effect concentrations were statistically compared in S-plus (TIBCO Software 191 
Inc., Palo Alto, CA) by means of a One-way ANOVA analysis and the significance of 192 
individual differences were calculated using Tukey post hoc tests. 193 
 194 
3. RESULTS 195 
3.1. Optimization 196 
First, we optimized and benchmarked our assay in terms of sensitivity, stability and 197 
specificity. When using fluorescent dyes, there is a risk of active dye uptake (e.g. by 198 
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pinocytosis) leading to compartmentalization of the dye in vesicles [11]. Indeed, using 199 
epifluorescence microscopy, we found that the fluorescent dye showed significant 200 
compartmentalization when the dye was loaded at 37°C. By lowering the loading temperature 201 
to 19°C, we observed a homogeneous cellular distribution of the dye indicating passive 202 
diffusion into the cell. 203 
Given that a complete experiment, corresponding to one 96-well plate, takes about one 204 
hour to screen, it is imperative that the cellular response in different wells remains stable 205 
through time. When performing pilot experiments using the plate reader, we observed at 37°C 206 
a gradual decrease in cell response to a single concentration of CCK-8S (0.1 and 1 nM) from 207 
well to well. Conversely, at lower temperatures (28°C) a gradual increase in response was 208 
observed. The most stable overall response through time was obtained at a measurement 209 
temperature of 31°C (Supplementary Fig. 2). 210 
To ensure ligand specificity, native CHO-K1 cells were included in the assay as 211 
negative controls. When stimulated with CCK-8S, CHO-K1 cells did not show a significantly 212 
different response from cells treated with buffer. However, both CHO-K1 as CHO-CCK1R 213 
showed a similar response when stimulated with TRAP-7, an agonist for the thrombin 214 
receptor (Supplementary Fig. 3). This confirmed that CHO-K1 cells could be used to correct 215 
for non-specific responses.  216 
 217 
3.2. The plate reader assay allows for sensitive and accurate measurement of agonist and 218 
antagonist effects on the cell population level 219 
First, we measured the cellular response to the natural ligand, CCK-8S. The change in 220 
fluorescence was monitored in time for increasing concentrations of CCK-8S (0.001 nM–1 221 
nM) (Fig. 1). Typically, RF curves (Fig. 1a) showed strong dose-dependent kinetics in terms 222 
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of the time point and height of the maximum RF, but also in terms of peak persistence. The 223 
integrated area below the curve incorporates these different parameters and was therefore 224 
used in the calculations. A significant increase in signal could be detected down to a 225 
concentration of 0.01 nM CCK-8S. Dose-response curves were established from calculating 226 
the net response per condition (Fig. 1b) and were used to derive the EC50 values (Table 1).  227 
Next, the effect of a partial agonist, JMV-180, was determined. The EC50 of JMV-180 228 
was 1,000-fold higher with respect to the natural ligand, pointing at a much lower affinity 229 
towards the receptor (Table 1). Moreover, the maximum response that could be evoked by 230 
JMV-180 compared to 1 nM CCK-8S was more than halved (mean ± SEM; 38 ± 8%), 231 
illustrating the lower potency of this partial agonist to activate the CCK1R (Supplementary 232 
Fig. 4a).  233 
In addition to the aforementioned agonists, the full antagonist lorglumide was tested 234 
for its potential to inhibit a CCK-8S-induced response. Increasing concentrations of 235 
lorglumide clearly demonstrated a dose-dependent inhibition of the response to 1 nM CCK-236 
8S. The IC50 value was 3 ± 1 µM (Supplementary Fig. 4c, Table 1). Full inhibition of 1 nM 237 
CCK-8S was obtained at 40 µM lorglumide.  238 
 239 
3.3. Confocal microscopy provides both population as well as single-cell information 240 
Using confocal microscopy, the same kinetic experiments were performed as with the plate 241 
reader. First, the population-average response was determined on whole images. Per well, one 242 
single region was acquired at full field of view (636 µm x 636 µm), corresponding to 100-150 243 
cells, and the average pixel intensity was measured over the entire image through time (Fig. 244 
2a, Supplementary Movies 1 and 2). This assay was performed for CCK-8S with and without 245 
lorglumide and for JMV-180 and resulted in highly similar RF curves, dose-response curves 246 
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and median effective concentration values (EC50 and IC50) as those obtained for the plate 247 
reader (Fig. 2b,c; Table 1; Supplementary Fig. 4b,d).  248 
To determine the actual single-cell response, we measured fluorescence kinetics in 249 
individual cells by means of automated image analysis (Fig. 3a, Supplementary Fig. 1). The 250 
individual fluorescence kinetics in time varied from cell to cell, not only in magnitude and 251 
time point of the maximum fluorescence intensity but also in fluorescence fluctuation 252 
behavior (Supplementary Fig. 5). The time lag between the moment of sample addition and 253 
the moment of maximum fluorescence intensity became progressively shorter with increasing 254 
agonist concentration. In parallel, the synchrony with which the fluorescence of individual 255 
cells changed increased as well. This is reflected in the magnitude of the standard deviation of 256 
the time point of maximum fluorescence (Supplementary Fig. 6). Especially at low doses a 257 
cellular behavior became evident that was not observed in population averages: calcium 258 
fluxes show several less intense oscillations after the first primary fluorescence peak 259 
(Supplementary Fig. 5g). These fluctuations were no longer observed from a dose of 0.1 nM 260 
CCK or higher. At high concentrations, the oscillatory mode changed into one single increase 261 
after which no oscillations are seen anymore. In brief, fluorescence kinetics In CCK-8S 262 
stimulated cells became more uniform with increasing concentrations, which is in accordance 263 
with earlier observations [20]. In comparison, fluorescence oscillations were more 264 
pronounced in cells treated with JMV-180 and also persisted at higher doses (Supplementary 265 
Fig. 7).  266 
Despite the inherent variability, all doses were significantly different from each other 267 
(Fig 3a). The median effective concentrations (EC50 and/or IC50) based on single-cell analysis 268 
were not significantly different from those based on the average image intensity nor from 269 
those derived from the plate reader (Table 1).  270 
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 To determine the robustness of the single-cell analysis, we calculated the number of 271 
cells required to discriminate dose-dependent responses using an in silico approach. To this 272 
end, image data sets containing all individual cell responses were progressively eroded by 273 
omitting one single, randomly selected cell at a time (on permutated data sets), down to one 274 
single cell, and by calculating the average response with each step. This was repeated 100 275 
times to obtain a distribution that represents the variability within the data set (Fig. 3b). The 276 
covariance (std/mean) plots of these distributions demonstrated that as little as 10 cells are 277 
sufficient to determine the population mean with 95% accuracy, or 25 cells are sufficient to 278 
determine the population mean with 97.5% accuracy (Fig. 3c). In silico erosion was 279 
performed for all experiments and confirmed that 10-20 cells are sufficient to determine the 280 
population mean with 95% accuracy (Supplementary Fig. 8).  281 
 282 
4. DISCUSSION 283 
We have established a robust cell-based bioassay to screen for compounds which activate 284 
CCK1R or inhibit its binding to the natural ligand, and which works on two different 285 
platforms. This technology was first developed by Foltz et al. [9] for a fluorescence plate 286 
reader. We have now optimized this technology by making it more sensitive, specific and 287 
more robust by cross-validating this assay on a different platform, namely the confocal 288 
microscope. During optimization, we discovered that lowering the loading and measurement 289 
temperature had an important influence on the sensitivity and temporal stability of the cell 290 
response. It is conceivable that the degree of cell compartmentalization and the decay of the 291 
fluorescence through time, which were observed at higher temperatures, are due to a higher 292 
cell metabolism. At higher temperatures, transport mechanisms like endocytosis/pinocytosis 293 
(leading to compartmentalization) and exocytosis (leading to loss of signal) become more 294 
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prominent [11] and active breakdown of the fluorescent dye could be promoted [6].  295 
 The EC50 measured for CCK-8S in this project with the fluorescence plate reader and 296 
the confocal microscope were not significantly different, although purely based on the SEM 297 
one could say a higher accuracy was obtained with the plate reader. This could be due to a 298 
different demand for manual interaction between both approaches: the measurements with the 299 
fluorescence plate reader were almost fully automated, whereas the measurements with the 300 
confocal microscope were carried out manually, thereby introducing pipetting inaccuracies 301 
and causing complete experiments to last longer and have more fluorescent probe decay. 302 
Also, sample mixing in the medium may have occurred faster in the plate reader causing cells 303 
to react more synchronously. On the other hand, a bigger SEM in confocal measurements may 304 
be the reflection of the high heterogeneity between individual cells, as such providing more 305 
accurate information of the true cellular response. In addition, the visualization of cells allows 306 
immediate verification of cellular health and density. Confocal microscopy also allows 307 
discrimination of off-target effects like bad solubility and background fluorescence of the 308 
sample (e.g. when protein hydrolysates are tested). With the fluorescence plate reader, 309 
autofluorescence of the sample causes a major concern as the fluorescent signal of the entire 310 
well is measured, which may obscure more subtle fluorescence increases at the level of the 311 
cells. In contrast, the confocal microscope only detects fluorescence in a selected focal section 312 
on the bottom of the well, which is predominantly from within the cells. Hence, due to its 313 
optical sectioning capability, confocal microscopy allows measuring a more specific response 314 
and testing higher sample concentrations when working with autofluorescent samples.  315 
Experiments carried out with cells in suspension under continuous stirring revealed 10 316 
to 50-fold higher EC50 values (around 0.19-1.08 nM) for CCK-8S compared to our 317 
experiments [4,8,14]. However, the EC50 of the partial agonist JMV-180 measured with cells 318 
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in suspension (25 nM) was comparable to the EC50 measured in this project [14]. These 319 
variations could not be ascribed to large differences in medium composition (e.g. BSA 320 
concentration) or probenecid concentration, but may be due to differences in sample 321 
composition and stability as well as the experimental setup. Receptor activation can also be 322 
measured by inositol trisphosphate (IP3) production. Cawston et al. [5] reported an EC50 value 323 
for IP3 production of JMV-180 of 18 nM, which is similar to the EC50 value of JMV-180 we 324 
found for Ca2+-increase (Table 1). In addition, the maximum concentration only induced 9% 325 
of the IP3 production compared to that of CCK-8S. The lower potency of JMV-180 compared 326 
to the natural ligand can be explained by the differential positioning of the C-terminal end 327 
within the binding site of CCK1R [1]. A partial agonist only exerts a subset of the biological 328 
functions of the natural ligand and therefore has a reduced tendency to evoke side effects and 329 
cause receptor intolerance. This makes a partial agonist more suitable as a therapeutic than the 330 
natural ligand [5]. In this context, it is also noteworthy that JMV-180 elicited highly different 331 
fluorescence kinetics compared to CCK-8S. In accordance with previous observations 332 
[15,17], more pronounced and more frequent oscillations were observed, even at high doses, 333 
indicating an altered cellular response. These differences could be due to differential coupling 334 
of low- and high affinity CCK1R binding sites to second-messenger systems and Ca2+-signal 335 
transduction pathways, e.g. differences in activation of protein kinase C and IP3 production 336 
[18,21]. Lorglumide is a full antagonist of the CCK1R and it is 2,300 times more selective for 337 
CCK1R than for CCK2R. It is a potent inhibitor in comparison to other glutaramic acid 338 
analogues [2]; an IC50 value of 0.13 µM was reported by Makovec et al. [10] for this 339 
antagonist. The latter IC50 value is 15 times lower compared to the IC50 measured in this 340 
project, which is probably due to the use of a different experimental design. Hence it can be 341 
concluded that comparison between the median effect concentrations (EC50 and IC50) of 342 
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different CCK receptor agonists and antagonists between studies should be made with 343 
caution, as different cell types, measuring techniques and controls are used. Therefore, we 344 
propose this standardized procedure to enable comparison of the CCK1R activity of different 345 
ligands. Moreover, with little adaptations, this assay could be converted into a screening 346 
system for ligands for the CCK2R, the sulfakinin receptor and other Ca2+-influencing GPCRs. 347 
In conclusion, the proposed cell-based bioassay can be used to screen for protein 348 
hydrolysates and molecules with CCK1R activity in a standardized manner. Measurement can 349 
be accomplished on two platforms. The fluorescence plate reader is more suitable to perform 350 
a primary screen, but the confocal microscope can be used to validate the activity of the 351 
components on the single-cell level, especially in a context of strong autofluorescence 352 
background. The selected components might be an aid in the battle against obesity or other 353 
CCK1R-involved diseases like diabetes type II.  354 
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Figure legends 422 
Fig. 1. Dose-dependent CCK1R-mediated calcium fluxes in cell populations monitored with a 423 
plate reader. (a) Kinetics of relative fluorescence (RF) of Fluo-4AM labeled CHO-CCK1R 424 
cells to increasing concentrations of CCK-8S (0.001–1 nM). The curves represent the mean of 425 
5 technical replicates (wells). (b) Representative dose-response curve for CCK based on 4 426 
experiments (biological replicates) in which the measurements for each concentration were 427 
repeated 5 times, expressed as a percentage of the maximum net response, i.e. the net 428 
response induced by 1 nM CCK. 429 
 430 
Fig. 2. Dose-dependent CCK1R-mediated calcium fluxes in cell populations monitored with a 431 
resonant scanning confocal microscope. (a) Montage from in fluxo confocal microscopy, 432 
combined from equally cropped regions selected from raw time-lapse series, acquired as 433 
described in the Materials and Methods section. (b) Kinetics of relative fluorescence (RF) of 434 
Fluo-4AM labeled CHO-CCK1R cells to increasing concentrations of CCK-8S (0.001–1 nM). 435 
The curves represent the mean of 5 technical replicates (wells). (c) Representative dose-436 
response curve for CCK based on 3 experiments (biological replicates) in which the 437 
measurements for each concentration were repeated 5 times, expressed as a percentage of the 438 
maximum net response, i.e. the net response induced by 1 nM CCK. 439 
 440 
Fig. 3. Dose-dependent CCK1R-mediated calcium fluxes in individual cells monitored with a 441 
resonant scanning confocal microscope (a) Boxplot representing the single-cell response of 442 
CHO-CCK1R cells to increasing concentrations of CCK-8S (0.001–1 nM), measured as the 443 
average intensity of individual cells and expressed as a percentage of the maximum response, 444 
i.e. the average response induced by 1 nM CCK. (b) In silico erosion. Per condition, the 445 
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response was calculated for all cells within one representative image per CCK-8S 446 
concentration. Next, cells were progressively removed from permutated data sets, one by one, 447 
down to the single cell and per step the average net response was calculated. This was 448 
repeated 100 times per condition. Every line represents one complete erosion cycle. (c) From 449 
the eroded data sets the covariance (CoV) was calculated and plotted as a function of the 450 
number of cells and represented on a logarithmic scale for visualization purposes. Ten cells 451 
reduce the CoV to 5% and 25 cells reduce the CoV to 2.5% (dotted black lines).  452 
453 
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Supplementary Material 454 
Supplementary Fig. 1. Illustration of temporal averaging for image segmentation. (a) 455 
original raw image of one single time point of a CHO-K1 cell labeled with Fluo-4AM 456 
acquired for 40 s at 3fps. (b) average intensity projection of the complete time stack (40 s, 150 457 
frames) (c) result of segmentation, displayed as white outlines superimposed on the average 458 
projection image. Scale bar represents 100 µm. 459 
 460 
Supplementary Fig. 2. Temperature and concentration dependence of cell response from 461 
well to well. Fluo-4AM CHO-CCK1R cells in 96-well plates were exposed to 0.1 nM (a) or 1 462 
nM CCK-8S (b) at different measurement temperatures. Every well, represented by a single 463 
data point in the plot, was treated (and measured) sequentially. Trend lines from a linear 464 
regression were plotted for demonstrational purposes. The response has been expressed 465 
relative to that of the first well. 466 
 467 
Supplementary Fig. 3. Kinetics of normalized fluorescence (Fi/F0) ± SD in Fluo-4AM 468 
labeled CHO-CCK1R and CHO-K1 to 250 µM of TRAP-7. Experiments were carried out in 469 
the presence of 50 µM lorglumide to inhibit effects via the CCK1R (n=6). 470 
 471 
Supplementary Fig. 4. Representative dose-response curves for JMV-180 (a,b) and 472 
lorglumide (c,d) based on 3 experiments in which the measurements for each concentration 473 
are repeated 5 times, expressed as a percentage of the maximum response and the percentage 474 
of inhibition from the maximum response, respectively. Graphs on the left are the results 475 
measured with the fluorescence plate reader (a,c) and on the right with the confocal 476 
microscope (b,d).  477 
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Supplementary Fig. 5. Inter-individual and temporal variation in normalized fluorescence 478 
kinetics (Fi/F0) in response to CCK-8S, monitored in Fluo-4AM labeled CHO-CCK1R cells 479 
with a resonant scanning confocal microscope, decreases with increasing concentration: (a) 480 
1E-03 nM, (b) 1E-02 nM, (c) 2.5E-02 nM, (d) 1E-01 nM, (e) 2.5E-01 nM, and (f) 1n M. (g) 481 
10 randomly selected curves from cells treated with 2.5E-02 nM CCK-8S demonstrate the 482 
fluorescence fluctuations in individual cells at low concentrations. 483 
 484 
Supplementary Fig. 6. Histogram comparing the average peak time (maximum fluorescence) 485 
of individual cells of all experiments, for increasing concentrations of CCK-8S, JMV-180 and 486 
lorglumide. Error bars represent standard deviations. 487 
 488 
Supplementary Fig. 7. Inter-individual and temporal variation in normalized fluorescence 489 
kinetics (Fi/F0) in response to JMV-180, monitored in Fluo-4AM labeled CHO-CCK1R cells 490 
with a resonant scanning confocal microscope, is more pronounced than after treatment with 491 
CCK-8S and persists with increasing concentration: (a) 5.0 nM, (b) 12.5 nM, (c) 50 nM, (d) 492 
125 nM, and (e) 500 nM. For comparison, (f) shows the profiles of Fluo-4AM labeled CHO-493 
K1 cells treated with 500 nM JMV-180. (g) 10 randomly selected curves from cells treated 494 
with 500 nM JMV-180 illustrate the persistence of fluorescence fluctuations in individual 495 
cells at high concentrations. 496 
 497 
Supplementary Fig. 8. Histogram comparing for all experiments the number of cells required 498 
to obtain a coefficient of variation of the cell response equal to or smaller than 5%, as 499 
calculated from in silico erosion data sets. Error bars represent standard deviations. 500 
 501 
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Supplementary Movie 1. Time-lapse recording (subregion of full field of view) of Fluo-502 
4AM labeled CHO-CCK1R cells acquired with resonant scanning confocal microscopy, 503 
stimulated in fluxo with 0.01 nM CCK-8S at 6 s of acquisition. A Green Hot lookup table was 504 
applied for accentuating intensity fluctuations. 505 
 506 
Supplementary Movie 2. Time-lapse recording (subregion of full field of view) of Fluo-507 
4AM labeled CHO-CCK1R cells acquired with resonant scanning confocal microscopy, 508 
stimulated in fluxo with 1 nM CCK-8S at 6 s of acquisition. A Green Hot lookup table was 509 
applied for accentuating intensity fluctuations. 510 
511 
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Table 1 512 
Median effect concentrations (EC50 and IC50) for the natural ligand CCK-8S, the partial 513 
agonist JMV-180 and the antagonist lorglumide, measured with the fluorescence plate reader 514 
(population average) and the confocal microscope (population average and single-cell). 515 
Median effect concentrations for a ligand do not significantly differ between measuring 516 
techniques, calculated with ANOVA followed by a post hoc Tukey test (df = 2; CCK-8S: F = 517 
3.05, p = 0.11; JMV-180: F = 0.48 p = 0.64; lorglumide: F = 0.72, p = 0.52). 518 
Ligand 
Median effect concentration (EC50 and/or IC50 ± SE) 
Fluorescence plate reader Confocal microscope 
Population average Population average Single-cell average 
CCK-8S 24 ± 4 pM 50 ± 13 pM 47 ± 13 pM 
JMV-180 20 ± 4 nM 31 ± 12 nM 31 ± 12 nM 
Lorglumide 3 ± 1 µM 4 ± 1 µM 5 ± 2 µM 
 519 
